Please login to the form below
British Medical Journal
This page shows the latest British Medical Journal news and features for those working in and with pharma, biotech and healthcare.
Half of European cancer drug trials ‘biased’, says BMJ
The paper – published in the British Medical Journal– examined 41 published trials reported between 2014 and 2016 that were used as evidence to support the approval of 32 cancer drugs.
Latest news
-
Amgen, Servier start second phase 3 trial of heart failure hope
Exercise intolerance, typically manifested by shortness of breath and fatigue on exertion, is a predominant symptom of chronic heart failure and often the first symptom that prompts patients to seek medical ... A recent British Medical Journal study
-
ABPI bid to overturn NICE’s budget impact rules fails
The Association of the British Pharmaceutical Industry (ABPI) has been fighting a legal action to try to overturn NICE’s introduction of a £20m cost ceiling for new drugs that have ... Last year, the NHS spent £16.8bn on medicines, according to the
-
Audit exposes gaps in pharma's promises on trial transparency
The audit - which is published in the British Medical Journal - reveals that the commitments made by pharma companies were ‘highly variable’.
-
NICE agrees £20m cost ceiling for new drugs
Last year, the NHS spent £16.8bn on medicines, according to the British Medical Journal, up 8% on the prior year and almost £4bn more than was spent in 2011. ... NICE has indicated they would consider broadening the fast-track approach to a wider group
-
Bayer defends Xarelto as pivotal trial scrutinised
Last week, the British Medical Journal also reported that the results of the trial are under scrutiny from regulators, specifically concerns that they may have exaggerated Xarelto's benefits.
More from news
Approximately 1 fully matching, plus 97 partially matching documents found.
Latest Intelligence
-
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
The role of publishers. There are examples of individual publications such as the British Medical Journal that are exploring the potential for patient involvement throughout the publication process, for example by ... using patient peer reviewers,
-
The Chinese diabetes challenge
according to a study recently published in the Journal of the American Medical Association (JAMA). ... Even the British Medical Journal (BMJ) has acknowledged that traditional Chinese medicine and Western medicine 'sit side-by-side' in China; therefore
-
Country report: The healthcare market in Japan
The number of suicides rose after the Kobe earthquake in 1995, which killed nearly 6, 500 people and the British Medical Journal reported in September 2011 that 'Japan's suicide rate ... Patients favour medical technology, such as scans, having them
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
M3 appoints Simon Walker as director of education
During this time he held senior sales positions with the British Medical Journal and in addition to this has also provided freelance consultancy services to agencies, pharmaceutical companies and publishers. ... It’s leading the field in medical
-
M3 appoints Paul Rice as chief operating officer
The company has also appointed Simon Walker as a business director working across its portfolio of promotional and medical education solutions on a global basis. ... Walker has over 20 years experience with the BMJ (British Medical Journal) and has also
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Practical Patient Centricity
addressing unmet medical needs, lives are improved and extended. ... The British Medical Journal requires companies to indicate the level of patient involvement in manuscripts for example.
-
Is Technology Harming Your Brain?
A Difference of Opinion. The article referenced a piece from the British Medical Journal in which three leading academics challenge Baroness Greenfield’s assertions.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- New study identifies drugs that are safe to use in COVID-19 treatment
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- New medical communications agency BOLDSCIENCE launches
- Moderna inks R&D agreements with Vertex and Chiesi
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Could formulary intelligence be your brand differentiator?
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Porterhouse Medical strengthens its senior management team
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
Latest intelligence
- Could formulary intelligence be your brand differentiator?
- Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
Quick links
Infographics
